For example, van Dijk et al [11] assessed 24-hour glycemia with a continuous glucose monitoring (CGM) device after bouts of resistance or aerobic exercise in individuals living with prediabetes not on medication, in individuals living with T2D on oral hypoglycemic medications, and in individuals living with T2D on insulin. The gene discussed is INS; the disease is prediabetes syndrome.